Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660

Article  CAS  PubMed  Google Scholar 

Mathur P, Sathishkumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S, Nallasamy V, John A, Narasimhan S, Roselind FS, ICMR-NCDIR-NCRP Investigator Group (2020) Cancer statistics, 2020: report from National Cancer Registry Programme, India. JCO Glob Oncol 6:1063–1075. https://doi.org/10.1200/GO.20.00122

Article  PubMed  Google Scholar 

Cancer Cervix Uteri [Internet]. Available from: https://ncdirindia.org/All_Reports/Report_2020/resources/Chapter8CancerCervixUteri.pdf. Accessed 12 Jul 2024 

Indian Council of Medical Research (2016) Consensus document for the management of cancer cervix. [Internet]  1–60 Available from: https://main.icmr.nic.in/sites/default/files/reports/CervixCancer.pdf. Accessed 12 Jul 2024 

Burmeister CA, Khan SF, Schäfer G, Mbatani N, Adams T, Moodley J, Prince S (2022) Cervical cancer therapies: current challenges and future perspectives. Tumour Virus Res 13:200238. https://doi.org/10.1016/j.tvr.2022.200238

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cohen AC, Roane BM, Leath CA (2020) Novel therapeutics for recurrent cervical cancer: moving towards personalized therapy. Drugs 80(3):217–227. https://doi.org/10.1007/s40265-019-01249-z

Article  PubMed  PubMed Central  Google Scholar 

Lo Muzio L, Pannone G, Staibano S, Mignogna MD, Rubini C, Mariggiò MA, Procaccini M, Ferrari F, De Rosa G, Altieri DC (2003) Survivin expression in oral squamous cell carcinoma. Br J Cancer 89(12):2244–2248. https://doi.org/10.1038/sj.bjc.6601402

Article  CAS  PubMed  Google Scholar 

Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N (2000) Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin cancer Res an Off J Am Assoc Cancer Res 6(1):127–134

CAS  Google Scholar 

Hirano H, Maeda H, Yamaguchi T, Yokota S, Mori M, Sakoda S (2015) Survivin expression in lung cancer: association with smoking, histological types and pathological stages. Oncol Lett 10(3):1456–1462. https://doi.org/10.3892/ol.2015.3374

Article  CAS  PubMed  PubMed Central  Google Scholar 

Byun S-S, Yeo WG, Lee SE, Lee E (2007) Expression of survivin in renal cell carcinomas: association with pathologic features and clinical outcome. Urology 69(1):34–37

Article  PubMed  Google Scholar 

Wang TT, Qian XP, Liu BR (2007) Survivin: potential role in diagnosis, prognosis and targeted therapy of gastric cancer. World J Gastroenterol 13(20):2784–2790. https://doi.org/10.3748/wjg.v13.i20.2784

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim HS, Shiraki K, Park SH (2002) Expression of survivin in CIN and invasive squamous cell carcinoma of uterine cervix. Anticancer Res 22(2A):805–8

CAS  PubMed  Google Scholar 

Frost M, Jarboe EA, Orlicky D, Gianani R, Thompson LC, Enomoto T, Shroyer KR (2002) Immunohistochemical localization of survivin in benign cervical mucosa, cervical dysplasia, and invasive squamous cell carcinoma. Am J Clin Pathol 117(5):738–744. https://doi.org/10.1309/6V09-38K3-JQ40-UR50

Article  PubMed  Google Scholar 

Albadari N, Li W (2023) Survivin small molecules inhibitors: recent advances and challenges. Molecules 28(3):1376. https://doi.org/10.3390/molecules28031376

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee JC, Chow NH, Wang ST, Huang SM (2000) Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients. Eur J Cancer 36(6):748–753. https://doi.org/10.1016/s0959-8049(00)00003-4

Article  CAS  PubMed  Google Scholar 

Niklińska W, Burzykowski T, Chyczewski L, Nikliński J (2001) Expression of vascular endothelial growth factor (VEGF) in non-small cell lung cancer (NSCLC): association with p53 gene mutation and prognosis. Lung Cancer 34(Suppl 2):S59-64. https://doi.org/10.1016/s0169-5002(01)00346-4

Article  PubMed  Google Scholar 

Wong C, Wellman TL, Lounsbury KM (2003) VEGF and HIF-1alpha expression are increased in advanced stages of epithelial ovarian cancer. Gynecol Oncol 91(3):513–517. https://doi.org/10.1016/j.ygyno.2003.08.022

Article  CAS  PubMed  Google Scholar 

Rahmani AH, Babiker AY, Alsahli MA, Almatroodi SA, Husain NEOS (2018) Prognostic significance of vascular endothelial growth factor (VEGF) and Her-2 protein in the genesis of cervical carcinoma. Open Access Maced J Med Sci 6(2):263–268. https://doi.org/10.3889/oamjms.2018.089

Article  PubMed  PubMed Central  Google Scholar 

Zhang J, Liu J, Zhu C, He J, Chen J, Liang Y, Yang F, Wu X, Ma X (2017) Prognostic role of vascular endothelial growth factor in cervical cancer: a meta-analysis. Oncotarget 8(15):24797–24803. https://doi.org/10.18632/oncotarget.15044

Article  PubMed  PubMed Central  Google Scholar 

Minion LE, Tewari KS (2017) The safety and efficacy of bevacizumab in the treatment of patients with recurrent or metastatic cervical cancer. Expert Rev Anticancer Ther 17(3):191–198. https://doi.org/10.1080/14737140.2016.1246187

Article  CAS  PubMed  Google Scholar 

Sanhueza C, Wehinger S, Castillo Bennett J, Valenzuela M, Owen GI, Quest AF (2015) The twisted survivin connection to angiogenesis. Mol Cancer 19(14):198. https://doi.org/10.1186/s12943-015-0467-1

Article  CAS  Google Scholar 

Fernández JG, Rodríguez DA, Valenzuela M, Calderon C, Urzúa U, Munroe D, Rosas C, Lemus D, Díaz N, Wright MC, Leyton L, Tapia JC, Quest AF (2014) Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K/Akt enhanced β-catenin/Tcf-Lef dependent transcription. Mol Cancer 9(13):209. https://doi.org/10.1186/1476-4598-13-209

Article  CAS  Google Scholar 

Tran J, Master Z, Yu JL, Rak J, Dumont DJ, Kerbel RS (2002) A role for survivin in chemoresistance of endothelial cells mediated by VEGF. Proc Natl Acad Sci U S A 99(7):4349–4354. https://doi.org/10.1073/pnas.072586399

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin L, Sun B, Liu Y, Zhao W (2017) Coexpression of survivin and livin predicts lymph node metastasis and poor prognosis in cervical cancer. Int J Clin Exp Pathol 1(10):6981–6988

Google Scholar 

Liu HQ, Wang YH, Wang LL, Hao M (2015) P16INK4A and survivin: diagnostic and prognostic markers in cervical intraepithelial neoplasia and cervical squamous cell carcinoma. Exp Mol Pathol 99(1):44–49. https://doi.org/10.1016/j.yexmp.2015.04.004

Article  CAS  PubMed  Google Scholar 

Cheng KY, Wang ZL, Gu QY, Hao M (2016) Survivin overexpression is associated with aggressive clinicopathological features in cervical carcinoma: a meta-analysis. PLoS ONE 11(10):e0165117. https://doi.org/10.1371/journal.pone.0165117

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Yan H, Li R, Guo Y, Zheng R (2019) High expression of survivin predicts poor prognosis in cervical squamous cell carcinoma treated with paclitaxel and carboplatin. Medicine (Baltimore) 98(20):e15607. https://doi.org/10.1097/MD.0000000000015607

Article  CAS  PubMed  Google Scholar 

Yanni A, Li Y, Zhao S (2018) The expression and underlying angiogenesis effect of DPC4 and VEGF on the progression of cervical carcinoma. Oncol Lett 15(2):2534–2540. https://doi.org/10.3892/ol.2017.7580

Article  CAS  Google Scholar 

Lv Q, Zhong W, Ye X, Lv Y, Liu H, Yan G, Chen D (2018) Expression of angiopoietin and VEGF in cervical cancer and its clinical significance. Open Life Sci 31(13):527–532. https://doi.org/10.1515/biol-2018-0063

Article  CAS  Google Scholar 

Zhang L, Chen Q, Hu J, Chen Y, Liu C, Xu C (2016) Expression of HIF-2α and VEGF in cervical squamous cell carcinoma and its clinical significance. Biomed Res Int 2016:5631935. https://doi.org/10.1155/2016/5631935

Article  CAS